Key points are not available for this paper at this time.
To evaluate the efficacy and safety of oral semaglutide for type 2 diabetes mellitus (T2DM) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).
Building similarity graph...
Analyzing shared references across papers
Loading...
Taeang Arai
Masanori Atsukawa
Akihito Tsubota
Diabetes Obesity and Metabolism
Nagoya City University
Nippon Medical School
Jikei University School of Medicine
Building similarity graph...
Analyzing shared references across papers
Loading...
Arai et al. (Mon,) studied this question.
www.synapsesocial.com/papers/68e59a18b6db6435875342f6 — DOI: https://doi.org/10.1111/dom.15898